In summary, MSCs exert anti-necrosis effects on APAP-injured hepatocytes to increase the survival of APAP-challenged mouse liver failure by secreting HGF, and the efficacy of transplanting MSCs is similar to those of the clinically used drug NAC. The gene discussed is HGF; the disease is Hepatic failure.